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The purpose of this study was to determine di¡erences
in iron and iron protein (ferritin and transferrin) levels
in chronic venous ulcers and acute wounds.The deleter-
ious e¡ect of iron in free-radical-induced tissue damage
was indirectly examined by assessing 8-isoprostane
levels and antioxidant status in wound £uid samples.
Wound £uid samples from chronic leg ulcers in non-
healing and healing phases and wound £uid from mas-
tectomy wounds were assayed for ferritin, transferrin,
total iron, 8-isoprostane, and total antioxidant status.
Immunohistochemistry and Perls’ staining were per-
formed on paired biopsies from chronic leg ulcers and
on normal skin biopsies. Chronic wound £uid had sig-
ni¢cantly greater levels of ferritin (po0.05) and lower
levels of transferrin (po0.001) than acute wound £uid
and there was a signi¢cant reduction in the level of fer-
ritin in healing compared to nonhealing chronic leg ul-
cers (po0.05). No signi¢cant di¡erences were observed
in the levels of total iron present in the wound £uids.
Histologic staining showed consistently more ferritin
and ferric iron in chronic wound tissue than in normal
skin. Elevated levels of 8-isoprostane and antioxidants
were observed for chronic wound £uid compared to
acute wound £uid (po0.001). These results suggest the
existence of an environment of oxidative stress in
chronic wounds and the likely contribution of iron to
exacerbating tissue damage and delaying healing in
these wounds. Key words: iron protein/lipid peroxidation/
wounds. J Invest Dermatol 121:918 ^925, 2003
I
t has been well established that venous hypertension and
the accompanying chronic in£ammation result in tissue da-
mage and ultimate skin ulceration (Angel et al, 1987; Cheatle
et al, 1991; Dormandy, 1997). Advances have been made in
venous ulcer research, suggesting that the impairment in
healing of these ulcers may be related to elevated and sustained
levels of in£ammatory cytokines and proteases in the wounds
(Trengove et al, 1999). A less well-studied factor in the cause of
venous ulceration is the in£uence of iron and free radical produc-
tion on wound repair.
Iron is the most abundant transition metal in the human body
and is an essential element for life (Fontecave and Pierre, 1993;
Okada, 1996). The toxicity of iron lies in its ability to undergo
cyclic oxidation and reduction reactions resulting in the genera-
tion of toxic free radicals via the Fenton reaction, which is cap-
able of initiating a sequence of biologic injury termed ‘‘oxidative
stress’’ (Ryan and Aust, 1992;Winterbourn, 1995). As a protective
measure against the toxicity of free iron in the biologic system,
iron within the body is sequestered in heme-containing proteins
and iron-binding proteins and is unreactive in this form unless it
is reduced and mobilized, thereby rendering it available for the
redox reaction (Ward et al, 1989; McCord, 1996).
The possibility of iron being a signi¢cant factor in venous ul-
cer formation was suggested as early as 1965 when Meyer noted
that ‘‘stasis’’ pigmentation is a common feature surrounding
venous ulcers and that it results from the deposition of hemosiderin
in the skin as a result of disintegrated red blood cells (Myers, 1965).
Ackerman et al (1988) reported that the brown pigmentation is
caused by increased dermal iron deposition and may have an active
role in perpetuating tissue damage in venous ulceration by augment-
ing local in£ammation, collagen deposition, and ¢brosis. Histologic
examination of tissue biopsies from venous ulcers has been reported
to show decreased hemosiderin levels with ulcer healing (Herrick et
al, 1992). A recent study showed total iron levels were increased in
chronic wound exudates compared to acute wound exudates and
human plasma (Wenk et al, 2001).
It has been hypothesized that continuing in£ammation, local
tissue hypoxia, and inappropriate activation of neutrophils exist
in venous disease and that these changes can lead to the genera-
tion of free radicals, which can then induce tissue damage (Angel
et al, 1987; Salim, 1991; Edwards et al, 1992; Whiston et al, 1994).
Increasing evidence of high iron levels in venous leg ulcer tissue
suggests that iron may participate in the process of tissue damage
as has been observed in numerous other in£ammatory disorders.
The aims of this study were to measure alterations in iron le-
vels and iron storage proteins (ferritin and transferrin) in wound
£uid collected from chronic leg ulcers and from acute mastect-
omy wounds, to examine the local deposition of ferric ion and
iron-containing protein in tissue sections from venous ulcers
and normal skin, and to examine oxidative damage within
chronic and acute wounds by measuring lipid peroxidation pro-
ducts, 8-isoprostane, and total antioxidant levels from these acute
and chronic wounds.
MATERIALS ANDMETHODS
Patient source and assessment All samples from venous leg ulcers in
this study were from patients who were attending the leg ulcer clinic at
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Fremantle Hospital for treatment of their leg ulcer. A thorough history and
examination was performed on patients and evidence of venous disease was
determined by demonstrating an abnormal venous re¢lling time on
photoplethysmography. Informed consent was obtained from each patient
and the use of biologic samples was approved by the Ethics Committee
from Fremantle Hospital. Patients considered for this study had failed
outpatient treatment with compression bandaging as evidenced by a lack
of reduction in ulcer size or by an increase in ulcer size. These patients
were all admitted to hospital for bed rest and split skin graft.
Collection of chronic wound £uid Chronic ulcer wound £uid was
collected from 21 patients who had evidence of venous disease, seven of
whom had additional factors contributing to the poor healing. The age
range was 28^88 y, with a median age of 76. The patients used in this
study had a 20% mean reduction in ulcer size during the 2 wk study.
There were 10 female and 11 male patients. The mean time that the ulcer
had existed was 13.5 mo with a range of 1.5^42 mo. Chronic wound £uid
samples were collected during the nonhealing phase on admission to
hospital, and during the healing phase after 2 wk of hospitalization. The
patients were fasted overnight and wound £uid was collected the
following morning by placing a transparent occlusive dressing (Opsite
dressing; Smith & Nephew, Hull, UK) over the ulcer and by placing the
leg in a dependent position.Wound £uid was allowed to accumulate under
the occlusive dressing for 2 h, during which the patient was encouraged to
drink up to 1 liter of water to aid in standardizing the state of hydration of
the patient.
The chronic wound £uid was carefully aspirated from beneath the
occlusive dressing using a sterile syringe and needle and was then
transferred into a collection tube and placed on ice. Wound £uid was
clari¢ed by centrifugation at 9,000 g at 41C (Eppendorf Centrifuge
5415C Eppendorf, Hamburg, Germany) for 10 min and then aliquoted
and stored at 801C (Forma Scienti¢c Freezer, Marietta, OH) until ready
for use.
One of the limitations of using chronic ulcer wound £uid for research is
the quantity. The wound £uid volume varies from patient to patient. For
this reason only a selection of patients who had enough wound £uid were
used for particular assays. In this study we used the maximum number of
patients possible for a particular assay.
Collection of acute wound £uid Acute wound £uid was collected
from 12 patients who had undergone a mastectomy. These patients had an
age range of 47^81y, with a median age of 70. Samples were collected at 24
h intervals from Redon-Vacuum drainage bottles, except for the ¢rst 24 h,
which was heavily blood stained. The wound £uid used for this study was
day 3 wound £uid, by which time there was very little blood in the drain
£uid and the sample was mostly serous £uid. This helped to limit the
potential excess iron from hemolysis. Acute wound £uid was clari¢ed by
centrifugation at 9,000 g at 41C for 10 min and was then aliquoted and
stored at 801C until analyses were performed.
Both chronic and acute wound £uids were centrifuged at 6,000 g at 41C
for 5 min after thawing before assays were performed.
Collection of leg ulcer tissue biopsies Following wound £uid
collection, tissue biopsies were taken under local anesthesia from each
patient. A rectangular section of tissue approximately 10 mm long, 3 mm
wide, and 5 mm deep was excised from the leg ulcer wound margin using
a scalpel blade. The area excised encompassed the surrounding intact skin,
the ulcer edge, and the ulcer base. The biopsy was immediately ¢xed in
formaldehyde solution and was then embedded in para⁄n wax and
sectioned at 4 mm for immunohistochemistry.
Collection of normal skin tissue Normal skin biopsies were collected
and were used as a comparison to leg ulcer tissue. The normal skin biopsies
were obtained from patients who underwent a below-knee amputation. A
tissue biopsy approximately 10 mm long, 3 mm wide, and 5 mm deep was
excised from the leg immediately after amputation, at a site furthest away
from the foot. The biopsies were ¢xed in formaldehyde solution and were
later embedded in para⁄n wax and used for immunohistochemistry.
Immunohistochemical and histochemical staining The detection of
ferric ions (Fe3þ) was carried out using Perls’ Prussian blue reaction (Dacie
and Lewis, 1984). In the reaction, sections were treated with an acidic
solution of potassium ferrocyanide (2% potassium ferrocyanide in
distilled water (wt/vol) (Sigma, St. Louis, MO) and 2% hydrochloric acid
(BDH Chemicals, Merk, Melbourne, Australia)) at room temperature for
15 min. Sections were counterstained with 2% Neutral Red (BDH) in
distilled water (wt/vol) for 5 min. Excess stain was cleared using distilled
water and 100% ethanol.
To determine the location of ferritin and transferrin, biopsy sections
were stained using polyclonal rabbit antihuman ferritin (Dako,
Copenhagen, Denmark) and polyclonal rabbit antihuman transferrin
(BioGenex Laboratories, San Ramon, CA) at concentrations of 1:1250 and
1:150, respectively. Tissue sections in this study were blocked with normal
swine serum at 10% in 0.05 M pH 7.6 Tris-bu¡ered saline for 10 min.
Sections were developed using Sigma FastTM DAB tablet set (Sigma) and
counterstained in hematoxylin. Color development was enhanced with
0.2% acid alcohol and Blueing solution.
Ferritin and transferrin assays The amount of ferritin and transferrin
in the wound £uid was determined using an immunoturbidimetric assay
from Boehringer Mannheim. Samples were analyzed using an automated
biochemical analyzer (Hitachi 911).
Total iron determination using Ferrozines assay and inductively
coupled plasma atomic emission spectrometry (ICP-AES) Total
iron level was measured using a modi¢ed form of the Ferrozines assay
(Yee and Goodwin, 1974). Wound £uid samples were acidi¢ed with 10%
HCl (BDH, AnalaR) at 371C for 45 min. The samples were further
acidi¢ed using 3.5% HCl/5% trichloroacetic acid (TCA; BDH, AnalaR)
at 371C for 45 min to release the iron from storage protein. Following
acidi¢cation and protein precipitation, the samples were centrifuged at
6,000 g for 10 min at 41C. Iron in the supernatant was reduced by 3.5%
HCl/5% TCA and reductant solution (thiourea and thioglycollic acid
in Milli-Q water) for 5 min. Color development was achieved using
Ferrozine and ammonium acetate bu¡er for a further 10 min. The assay
was carried out on 96-well £at bottom plates (Falcon BD-Biosciences,
Franklin Lakes, NJ) and absorbance was read at 550 nm wavelength using
a plate reader (Milenia,TM Kinetic Analyzer Diagnostic Products
Corporation, Los Angeles, CA) at the 60 min time point. A standard
solution was prepared using ferrous sulfate.
ICP-AES (also known as ICP-OES, inductively coupled plasma optical
emission spectrometry) was used to determine the total iron levels in both
acute and chronic wound £uid. Wound £uid was acidi¢ed and protein
precipitated as described in the methodology for the Ferrozine assay. For
this assay a three-point standard curve was prepared using ferrous sulfate
and standard solutions were treated in the same way as the unknown
samples. Standard and wound £uid samples were analyzed in duplicate at
a wavelength of 261.187 nm.
Measurement of 8-isoprostane (8-iso-PGF2a) by enzyme immunoassay
(EIA) and gas chromatography/mass spectrometry The extent of
oxidative damage was determined by measuring the levels of 8-isoprostane in
the wound exudates from chronic and acute wounds using an EIA from
Cayman Chemical, and a small number of samples were also examined using
gas chromatography/electron capture negative ionization mass spectrometry
(GC-ECNI-MS) with 8-iso-PGF2a-d4 as an internal standard.
Sample preparation was carried out prior to assaying, ¢rst by extraction and
hydrolysis and then by puri¢cation. Determination of free 8-isoprostane was
carried out using 150 mL of acute/chronic wound £uid made up to 2 mLwith
Baxter water and acidi¢ed to pH 3 with 2 M HCl. A highly speci¢c activity
tritium tracer, tritium-labeled PGF2a ([
3H]-PGF2a) at 5000 cpmwas added prior
to puri¢cation. The percentage of recovery of the tracer ranges from 50% to
70% for di¡erent acute and chronic wound £uids. Samples were assayed in
duplicate and the intra- and inter-reproducibilities were consistent.
Sample puri¢cation was carried out by reversed-phase chromatography with
C18 Sep-Pak cartridge (Waters,
TM Millipore, Millford, MA) using a series of
solvents of decreasing polarity. The Sep-Pak cartridge was preconditioned by
rinsing with 5 mL methanol and then with 5 mL pH 3 Baxter water by
applying gentle vacuum and ensuring that the cartridge did not dry out. The
2 mL spiked sample was applied onto the cartridge followed by 10 mL pH 3
water, 10 mL acetonitrile (CH3CN)/water (15:85), and 10 mL petroleum spirit
(40^601C). The 8-isoprostane was then eluted using 10 mL ethyl acetate/
petroleum spirit (50:50) into a polypropylene tube, dried with anhydrous
MgSO4, and transferred into a new polypropylene tube. Prior to use the ethyl
acetate/petroleum spirit was evaporated to dryness under a stream of dry
nitrogen and the sample was reconstituted by adding 1 mL of EIA bu¡er and
was vortexedwell. An aliquot of 500 mL of this sample was used for scintillation
counting and the remaining sample was used for EIA analysis. The extracted
sample was assayed as outlined in the kit. The plate was read at 405 nm
wavelength using a MileniaTM kinetic analyzer.
Measurement of F2-isoprostane in acute and chronic wound £uid using silica
and C18 reversed-phase extraction, high-performance liquid chromatography
(HPLC), and GC-ECNI-MS was carried out as outlined in Trevor et al (1999)
and in Proudfoot et al (1999). In brief, sample puri¢cation was carried out as
described for the EIA with an additional cleansing step. Following eluting
from C18 Sep-Pak, the sample was reloaded onto a Silica Sep-Pak cartridge
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(Waters, Millipore), washed with ethyl acetate, and ¢nally eluted using 5 mL of
ethyl acetate:methanol (50:50). The eluate was evaporated to dryness,
reconstituted in 40 mL of methanol, and separated by HPLC. Fractions were
collected at the 14.5^15.5 min mark and dried under nitrogen gas.
Derivatization was carried out on the F2-isoprostane fraction by treating with
penta£uorobenzoyl bromide (40 mL, 10% vol/vol in acetonitrile) and N,N-
diisopropylethylamine (20 mL, 10% vol/vol in acetonitrile) at room
temperature for 30 min. The sample was then dried under nitrogen gas and
treated with N,O-bis(trimethylsilyl)tri£uoroacetamide and trimethylchlorosi-
lane (99:1) (20 mL) and anhydrous pyridine (10 mL) at 451C for 20 min. The
sample was again dried under nitrogen gas. For GC-ECNI-MS the sample
was reconstituted in 25 mL of decane (iso-octane) and analyzed on a Hewlett-
Packard HP 5890 Series II Plus gas chromatograph coupled to an HP 5989B
mass spectrometer (Hewlett-Packard, Palo Alto, CA). F2-isoprostanes were
detected by monitoring m/z 569 and 573 for 8-iso-PGF2a-d4.
All samples used for the determination of 8-isoprostane by EIA and GC-
ECNI-MS have added tracer and the amount recovered has been taken into
account and the ¢nal values reported has been corrected for recovery.
Total antioxidant status assay Antioxidant activity in the wound £uid
was measured using Randox total antioxidant status assay. This assay is
designed for antioxidant determination in serum.We felt the assay would
give an indication of the overall antioxidant status in wound £uid in view
of its similarity to serum. Measurement was carried out using a Cobas
Fara centrifugal analyzer. The assay was performed by incubating
ABTS (Roche, Basel, Switzerland) (2,20 -azino-di-[3-ethylbenzthiazoline
sulfonate]) with a peroxidase (metmyoglobin) and hydrogen peroxide to
generate a radical cation ABTS  þ. This radical has a relatively stable blue-
green color, which can be detected at 600 nm.The antioxidant present will
prevent the conversion of ferrylmyoglobin to ABTSs  þ and
metmyoglobin, and the degree of inhibition is proportional to the
concentration of antioxidants in the sample.
Statistical analysis Paired chronic wound £uid samples (nonhealing and
healing) were compared statistically using theWilcoxon sign-rank test, and
unpaired samples (acute and chronic wound £uid) were analyzed using the
Mann^Whitney U test with the Statistical Package for Social Sciences
(SPSS, SPSS Inc, Chicago, IL).
Analysis with p-values of less than 0.05 was regarded as signi¢cant. The
results are expressed as median and 95% con¢dence intervals (CI) (Gardner
and Altman, 1989).
RESULTS
Iron protein levels in chronic nonhealing and healing
wound £uid and in acute wound £uid The ferritin levels in
the chronic and acute wound £uids are expressed as median and
95% CI. This gives a very accurate presentation of the spread of
the data. Ferritin levels in chronic nonhealing wound £uid had a
median of 2.96 mg per L, 95% CI (1.50, 4.63) mg per L. The
median level for chronic healing wound £uid was 1.56 mg per L,
95% CI (1.27, 2.37) mg per L, and for acute mastectomy wound
£uid was 1.10 mg per L, 95% CI (0.55, 1.27) mg per L. A
signi¢cant di¡erence in ferritin level was evident between acute
and chronic wound £uid and during the healing of chronic leg
ulcers (Fig 1). A summary of all the results for the di¡erent
assays used in this study is presented at the end of the Results.
The data for transferrin levels in wound £uid are presented as
median and 95% con¢dence intervals. The median level for
transferrin in nonhealing chronic wound £uid was 13 mmol per L,
95% CI (12, 15) mmol per L.The median level for healing chronic
wound £uid was 14.5 mmol per L, 95% CI (12, 17) mmol per L, and
the median for acute wound £uid was 18.5 mmol per L, 95% CI
(14, 20) mmol per L. In contrast to ferritin measurements,
transferrin levels in wound £uid were higher in acute wound
£uid compared to nonhealing chronic wound £uid. No
signi¢cant di¡erences were observed between the nonhealing
and healing chronic wound £uid or healing chronic wound
£uid and acute wound £uid (Fig 2).
Total iron levels in wound £uid using the Ferrozine assay
and ICP-AES The total iron level in wound £uid was
measured using two methods, Ferrozine assay and ICP-AES. The
levels of iron measured in the wound £uid using the Ferrozine
assay were as follows: chronic nonhealing wound £uid 3.82 mg
per mL, 95% CI (1.87, 5.64) mg per mL; chronic healing wound
£uid 3.18 mg per mL, 95% CI (1.57, 5.52) mg per mL; and acute
wound £uid 2.84 mg per mL, 95% CI (2.56, 5.6) mg per mL. By
comparison the total iron levels in wound £uid detected by ICP-
AES were as follows: chronic nonhealing wound £uid 5.84 mg
per mL, 95% CI (3.48, 12.65) mg per mL; chronic healing wound
Figure1. Ferritin levels in acute and chronic wound £uid. The re-
sults for the ferritin assay on 22 pairs of chronic wound £uids showed a
signi¢cant decrease in the level of ferritin during the healing of chronic
leg ulcers (Wilcoxon; po0.05). There were signi¢cantly higher levels of
ferritin in chronic wound £uid at both healing phases compared to acute
wound £uid (Mann^Whitney U test; po0.001).The immunoturbidimetric
assay, Tina-quant-Ferritin, was conducted using 10 mL of wound £uid.
Chronic wound £uid was diluted 1 in 2 with 0.9% sodium chloride solu-
tion and acute wound £uid was assayed undiluted. The turbidimetric mea-
surement of absorbance 0^700 nm is directly proportional to the
concentration of ferritin in the wound £uid.
Figure 2. Transferrin levels in acute and chronic wound £uid. The
transferrin levels for the 22 pairs of chronic wound £uid (nonhealing and
healing phases) and 12 samples of acute wound £uid showed signi¢cantly
higher transferrin levels in acute wound £uid compared to nonhealing
chronic wound £uid (Mann^Whitney U test; po0.01) as denoted by an
asterisk. A wound £uid volume of 2 mL was su⁄cient for the assay, and
both acute and chronic wound £uids were assayed neat using the Tina-
quant assay with a Hitachi 911 automated analyzer.
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£uid 3.76 mg per mL, 95% CI (1.88, 9.44) mg per mL; and acute
wound £uid 4.99 mg per mL, 95% CI (3.54, 5.89) mg per mL.
The total iron detected using the Ferrozine assay was lower
compared to ICP-AES. However, the trends were the same for
all wound £uid types. In spite of obvious di¡erences in the
levels of ferritin between the wound £uid types, the deter-
mination of total iron in wound £uid based on the Ferrozine
assay showed no signi¢cant di¡erences in the levels of iron
present in the di¡erent wound £uids. Similarly, the results
obtained using ICP-AES showed no signi¢cant di¡erences in
total iron levels in the di¡erent wound £uids (Fig 3).
Ferritin staining in tissue biopsies Immunohistochemical
staining was performed on 12 pairs of chronic ulcer biopsies
from the nonhealing and healing phases. Qualitative assessment
revealed very little to no positive staining in the intact epidermis
and slightly more positive staining in the ulcer-edge epidermis.
By comparison to the epidermis there was considerably more
positive staining throughout the dermal region of the tissue. The
patterns of staining in the intact skin, ulcer edge (epidermis and
dermis), and ulcer base (dermis) were similar in biopsies from
nonhealing ulcers and from healing ulcers. Ferritin staining in
both the dermis and the epidermis appeared to be located
intracellularly and staining was also present in the extracellular
matrix in the dermis (Fig 4A). By comparison, ferritin staining
performed on two normal skin tissues was considerably less than
in ulcer tissues. The positive staining was con¢ned speci¢cally
to the dermal region with very little or none evident in the
epidermis (Fig 4B).
Transferrin staining in tissue biopsies Immunohistochemistry
for transferrin was performed on 12 pairs of nonhealing and
healing leg ulcer biopsies. Qualitative analyses showed positive
staining predominately in the epidermis, which was more
pronounced in the epidermis at the ulcer edge than in the
adjacent intact skin. There was less intense staining in the dermis
than in the epidermis.
Localization of ferric ion in tissue biopsies The Perls’
Prussian blue reaction for ferric ion was performed on eight
pairs of nonhealing and healing biopsies. Ferric ion was
localized only in the dermal region of the tissues, with little or
no positive staining in the epidermis of the intact skin or the
ulcer edge. The degree of ferric ion staining was greater in
the dermis of the ulcer edge and the ulcer base compared to the
dermis beneath the intact skin (Fig 5A). No obvious change in
the intensity and/or distribution of ferric ion was observed
during the healing of leg ulcers. In normal skin tissue, there was
very little or no positive staining for ferric ion in the dermis or
epidermis (Fig 5B).
8-Isoprostane levels in acute and chronic wound £uids To
examine the extent of lipid peroxidation in acute and chronic
wounds, free-form 8-isoprostane or 8-epi-PGF2a, a non-
enzymatic peroxidation product of arachidonic acid, was measured
in the wound £uid from these wounds. 8-Isoprostane levels
were measured using an EIA and by GC-ECNI-MS. Ana-
lysis showed that higher levels of 8-isoprostane was detected by
EIA than GC-ECNI-MS. The trends were the same for the
di¡erent wound £uid types, however, and were con¢rmed
Figure 3. Iron levels in di¡erent wound £uid types using the Ferro-
zine assay and ICP-AES. The Ferrozine assay was performed on eight
pairs of chronic nonhealing and healing wound £uid samples and eight
day 3 samples of acute wound £uid. ICP-AES was used to investigate the
iron levels in 14 pairs of chronic wound £uid and 13 day 3 samples of acute
wound £uid. The two independent iron measurement methods showed
that total iron levels were not signi¢cantly di¡erent between the wound
£uid types. Iron determination by Ferrozine assay was conducted using
100 mL of wound £uid diluted 1 in 2 with Milli-Q water. Acidi¢cation
and protein precipitation was carried out using 40 mL of 10% HCl and
3.5% HCl/5% TCA, respectively. Iron in the supernatant (10 mL) was re-
duced using 3.5% HCl/5% TCA and 30 mL of reductant solution, and col-
or development was achieved with 30 mL of Ferrozine reagent and 30 mL of
ammonium acetate solution. ICP-AES was conducted using 100 mL of
wound £uid, which was acidi¢ed and protein was precipitated as described
for the Ferrozine assay. The supernatant collected was made up to 2 mL
with Milli-Q water and analyzed at a wavelength of 261.187 nm.
Figure 4. Distribution of ferritin in leg ulcer in normal skin.
(A) Ferritin staining in nonhealing leg ulcer tissue. Immunohistochemistry
staining for ferritin in a nonhealing leg ulcer tissue biopsy showed exten-
sive distribution of ferritin in both the dermis and the epidermis. Ferritin
staining (brown) appeared to be located intracellularly and extracellularly in
the matrix as depicted at 20 magni¢cation. (B) Ferritin staining in nor-
mal skin tissue. Immunohistochemistry staining for ferritin in normal
skin tissue was considerably less or not evident in the tissue as depicted
at 20 magni¢cation.
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statistically. The median and con¢dence intervals of the EIA
results were as follows: chronic nonhealing wound £uid 2.29 ng
per mL, 95% CI (1.42, 4.58) ng per mL; healing wound £uid 1.83
ng per mL, 95% CI (0.99, 3.29) ng per mL; and acute wound £uid
0.51 ng per mL, 95% CI (0.35, 0.75) ng per mL. The GC-ECNI-
MS results for chronic nonhealing wound £uid were 0.70 ng per
mL, 95% CI (0.33, 1.45) ng per mL; healing wound £uid 0.64 ng
per mL, 95% CI (0.39, 0.95) ng per mL; and acute wound £uid
0.30 ng per mL, 95% CI (0.22, 0.38) ng per mL (Fig 6).
The EIA and GC-ECNI-MS methods were analyzed
statistically using Pearson correlation coe⁄cients.Weighted least-
products regression was used to determine ¢xed bias and
proportional bias (Ludbrook, 1997). The Pearson correlation
between the EIA and GC-ECNI-MS methods was 0.907
(po0.001) and the weighted least-products regression showed
that there was a signi¢cant proportional bias as well as a ¢xed
bias. The di¡erence between the two methods increases as the
values increase and the EIA method is consistently higher than
the GC-ECNI-MS. The di¡erences in agreement of one method
with the other suggest that the two assays are not interchangeable
in absolute values, but they do provide good relative values from
one sample to the next.
Total antioxidant status in wound exudate There is an
elaborate defense mechanism to detoxify (metabolize) free
radicals in vivo, which may be nonenzymatic in origin. Total
antioxidant measurement will give an indication of the sum of
antioxidants present in the sample. The antioxidant status in
chronic wound £uid was signi¢cantly higher in nonhealing
samples compared to healing samples (p¼ 0.05). The median for
nonhealing chronic wound £uid was 2.33 mmol per L, 95% CI
(1.47, 2.57) mmol per L, compared to 1.45 mmol per L, 95% CI
(1.34, 2.11) mmol per L, for healing chronic wound £uid. The
levels in chronic wound £uid at both healing stages were higher
compared to acute wound £uid, median 1.13 mmol per L, 95% CI
(0.93, 1.21) mmol per L (po0.001) (Fig 7).
Figure 5. Distribution of ferric ion in leg ulcer and normal skin tissue.
(A) Ferric ion staining in nonhealing leg ulcer tissue. Using Perls’ Prussian
blue staining, there appears to be extensive ferric ion in the dermal region
of the leg ulcer tissue and very little or none evident in the epidermis.
Staining (blue) was predominately distributed extracellularly in the matrix.
(B) Ferric ion staining in normal skin tissue. For comparison, this is a Perls’
Prussian blue staining on a normal skin tissue showing very little or no
positive staining for ferric ion in the dermis or epidermis.
Figure 6. 8-Isoprostane levels in acute and chronic wound £uids
measured by EIA and GC-ECNI-MS (median and 95% CI). A total
of 13 pairs of chronic wound £uid and 15 samples of acute wound £uid
were analyzed by EIA. There was no signi¢cant change in the level of free
8-isoprostane observed during the healing of chronic leg ulcers. Compar-
ison with acute wounds, however, showed that 8-isoprostane levels were
signi¢cantly higher by 3^4-fold (po0.001) in both healing stages of
chronic wounds compared to acute wounds.The same trends were also ob-
served using GC-ECNI-MS based on four pairs of chronic wound £uid
and ¢ve samples of acute wound £uid. Chronic wound £uid at both heal-
ing stages exhibited higher levels of 8-isoprostane by comparison to acute
wound £uid and no changes in levels during the healing of the ulcer. De-
termination of 8-isoprostane was carried using 150 mL of acute and chronic
nonhealing and healing wound £uid. The same sample preparation was
carried out prior to assay for both methods as described in Materials and
Methods and the extracted sample was read at 405 nm for the EIA and de-
tected by monitoring m/z 569 and 573 for 8-iso-PGF2a-d4.
Figure 7. Total antioxidant status in acute and chronic wound £uid
(median and 95% CI). The antioxidant activity in wound £uid was as-
sessed by measuring the total antioxidant status of 15 pairs of chronic
wound £uid and 20 samples of acute wound £uid. A higher level of total
antioxidant was observed in chronic nonhealing wound £uid compared to
healing wound £uid and between both chronic wound £uids and acute
wound £uid. For accuracy and reproducibility, Randox total antioxidant
control was used during the assay. The wound £uid used in the assay was
analyzed in neat concentration.
922 YEOH-ELLERTON AND STACEY THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Summary of the results A summary of all the results is
presented in Table I with median and 95% CI and median
di¡erences for the di¡erent wound £uid types and for the
di¡erent assays used in the study.
DISCUSSION
Iron-catalyzed generation of reactive oxygen species and of
oxidative stress have been implicated as important pathologic
mediators in many clinical disorders (Halliwell and Gutteridge,
1985; Cross et al, 1987), including ischaemia reperfusion injury
(McCord, 1985), iron overload disorders (Lesnefsky, 1994), and in-
£ammatory skin conditions (Trenam et al, 1992).The contribution
of iron in the tissue damage in venous ulceration is less well un-
derstood, however (Ackerman et al, 1988). This study utilized
wound £uid and tissue biopsies to assess the changes in both iron
regulation and tissue damage in the healing process in both acute
and chronic wounds.
The toxicity of iron in the biologic system has resulted in it
being carefully sequestered in iron-binding proteins and its avail-
ability thereby being strictly regulated to minimize oxidative da-
mage. Under pathologic conditions such as in an in£ammatory
wound, however, in which there is a low pH, a partial ischaemic
state, and an excess of free radicals, these factors may cause the
release of iron from storage, thereby making it available to cata-
lyze the toxic hydroxyl radical, which can cause tissue damage.
In these studies elevated levels of ferritin were found in chronic
wound £uid from both healing phases compared to acute wound
£uid. There was also a signi¢cant reduction in ferritin levels in
the healing venous leg ulcers. The expression and induction of
ferritin protein synthesis are known to be highly regulated by
high iron levels (Saddi et al, 1974; Harford and Klausner, 1990;
Aust, 1995). The level of ferritin measured in wound £uid may
therefore be indicative of the amount of iron in the wound, just
as serum ferritin levels correlate with total body iron stores (Wal-
ters et al, 1973; Connelly et al, 1997). Studies have also shown that
pro-in£ammatory cytokines, interleukin-1b (Rogers et al, 1990),
tumor necrosis factor a (Miller et al, 1991), and interleukin-6
(Kobune et al, 1994), increase ferritin synthesis and that the in-
£ammatory process itself may also be responsible for the induc-
tion of ferritin synthesis (Konijn et al, 1981; Konijn, 1994). It has
been suggested that, although these cytokines may induce ferritin
synthesis, the presence of iron is still required for the e¡ect to be
fully expressed at the protein level (Miller et al, 1991; Hirayama
et al, 1993).The signi¢cant reduction in ferritin levels with healing
of chronic wounds observed in this study may have been partly
regulated by a decrease in the levels of pro-in£ammatory cyto-
kines, which has previously been reported during healing of ve-
nous ulcers (Trengove et al, 1994). Ferritin release into the
extracellular environment could also be a result of tissue damage
from macrophage phagocytosis induced by local bleeding or
could be due to infectious agents.
The level of transferrin was signi¢cantly higher in acute
wound £uid compared to nonhealing chronic wound £uid but
was not signi¢cantly di¡erent to healing chronic wound £uid.
Previous studies have shown that in£ammatory cytokines med-
iate transferrin secretion and synthesis (Castell et al, 1989). This
could be one reason why serum transferrin is depressed in chronic
disorders (Hirayama et al, 1993). The in£ammatory cytokines
present at high concentrations in chronic wounds could play
a role in downregulating transferrin levels in chronic venous
ulcers.
Total iron determination using both a chemical assay (Ferro-
zine assay) and a specialized atomic spectrometry (ICP-AES)
technique revealed no signi¢cant di¡erences in the iron levels be-
tween the wound £uid types. This ¢nding is in contrast to the
work performed byWenk et al (2001) who reported that iron in
chronic venous leg ulcer £uid was substantially higher than in
acute blister and mastectomy drainage £uid. It is important to
note that their group used a di¡erent iron assay and exudate col-
lection method, which may contribute to the di¡erences in our
¢ndings compared to theirs. It can be speculated that ferritin in
chronic wound £uid may not be completely saturated with iron
and may in fact be apoferritin, which is produced as an acute
phase protein in response to increased levels of in£ammatory
mediators. It is not known whether the form of the iron present
in acute and chronic wound £uid in this study could participate
in the Fenton reaction. This does warrant further investigation.
One of the main limitations of mastectomy £uid used for the de-
termination of iron is the likelihood of hemolysis in the sample.
A false indication of the actual iron levels in the wound is possi-
ble and interpretation of the total iron in acute wound £uid must
therefore be carried out cautiously. The use of acute wound £uid
for total iron determination may have its limitation. The decision
to use day 3 samples may have helped to limit the potential of
overestimating iron from hemolysis.
The histologic studies, which were based on immunoperoxi-
dase staining techniques, revealed extensive distribution of ferri-
tin in leg ulcer tissue compared to normal skin tissue. The
induction of ferritin synthesis in ulcer tissue could be regulated
by in£ammatory mediators or stimulated by increased iron con-
centration from local hemorrhage. This ¢nding correlated well
with wound £uid ferritin levels, which were found to be mark-
edly elevated in chronic wound £uid compared to acute wound
£uid. Tissue ferritin stores have been shown to be markedly in-
creased in iron overload diseases (Zuyderhoudt et al, 1983). Ferritin
is a potential source of iron for oxidative damage (Thomas et al,
1985; Reif, 1992), and if the regulation of iron within ferritin in
the wound environment was disrupted and the ferritin iron was
mobilized, this could contribute to free-radical-induced cell
damage.
Transferrin also has an important role in the regulation of iron
and in maintaining iron homeostasis. The immunohistochemical
staining in this study indicated the presence of transferrin protein
predominately in the epidermis of the leg ulcer biopsies with vir-
tually none in the epidermis of the normal skin tissue. There is
perhaps an increased demand for iron by epidermal cells for me-
tabolic processes such as oxygen transport, DNA synthesis, and
electron transport during wound repair. The hyperproliferative
Table I. Summary of the results as median (95% CI) n, for the di¡erent assays
Test
Chronic wound £uid,
nonhealing (Cwfnh)
Chronic wound £uid,
healing (Cwfh) Cwfnh  Cwfh Acute wound £uid
Ferritin (mg per L) 2.96 (1.50^4.63) 22 1.56 (1.27^2.37) 22 1.40 1.10 (0.55^1.27) 12
Transferrin (mmol per L) 13 (12^15) 22 14.5 (12^17) 22 1.5 18.5 (14^20) 12
Total iron (mg per mL)
Ferrozine 3.82 (1.87^5.64) 8 3.18 (1.57^5.52) 8 0.64 2.84 (2.56^5.60) 8
ICP-AES 5.84 (3.48^12.75) 14 3.76 (1.88^9.44) 14 2.08 4.99 (3.54^5.89) 13
8-isoprostane (ng per mL)
EIA 2.29 (1.42^4.58) 13 1.83 (0.99^3.29) 13 0.46 0.51 (0.350.75) 15
GC-ECNI-MS 0.70 (0.33^1.45) 4 0.64 (0.39^0.95) 4 0.06 0.30 (0.22^0.38) 5
Total antioxidant status (mmol per L) 2.33 (1.47^2.57) 15 1.45 (1.34^2.11) 15 0.88 1.13 (0.93^1.21) 20
IRON AND 8-ISOPROSTANE IN WOUNDS 923VOL. 121, NO. 4 OCTOBER 2003
activity observed at the edge of the ulcer could have resulted in an
increased demand for more iron, and consequently an increased
synthesis of transferrin. Transferrin synthesis can also be cytokine
mediated.
This work identi¢ed high levels of ferric ion in the dermis of
biopsies from healing and nonhealing ulcers compared to the
normal skin tissue. This provides evidence that tissue ferritin not
only is an acute phase reactant, which responds to in£ammatory
mediators, but could also be in£uenced by the presence of ferric
ion. As Prussian blue reaction stains nonspeci¢cally for ferric ion,
other ferric ion that is not bound to ferritin could also stain posi-
tive in the reaction. Other iron-binding proteins like hemosider-
in, lactoferrin, and transferrin can also bind and store ferric
ion. Heme from hemeproteins (hemoglobin, myoglobin, cyto-
chromes) or heme enzymes (guanylate cyclase, nitric oxide
synthase) (Ponka, 1999) is another possible source of ferric ion
in the dermis of ulcer tissue. The existence of an iron pool in the
ulcer tissue could lead to iron-derived reactive oxygen species and
irreversible tissue damage. Studies have shown that various vascu-
lar disorders such as atherosclerosis, vasculitis, and reperfusion in-
jury are developed from iron-derived oxidative damage. The
likely contribution of iron to the pathogenesis of venous ulcera-
tion cannot be discredited. Repeated vascular endothelium da-
mage may provide a source of catalytically active heme iron and
free radicals. The oxidation of hemoglobin facilitates the release
of heme, which can provide potentially damaging iron to the tis-
sue environment (Balla et al, 1993).
Iron participation in diverse pathologic processes by way of the
Fenton reaction could be involved in the initiation and perpetua-
tion of venous ulceration. This study has demonstrated the exis-
tence and persistence of iron-binding proteins (ferritin and
transferrin) in ulcer biopsies, supporting Ackerman’s ¢nding of
high levels of hemosiderin in venous stasis ulcers. More impor-
tantly this study has provided evidence of high levels of the toxic
ferric ion in ulcer tissue compared to nonulcerated skin that can
potentially participate in free radical reactions and cause irrepar-
able tissue damage.
Isoprostanes are prostaglandin-like compounds generated by
the free-radical-induced oxidation of unsaturated fatty acids (pri-
marily arachidonic acid) in membrane phospholipids. They are of
interest because of their biologic activity and because they are an
indicator of oxidative status in vivo (Morrow and Jackson Roberts,
1996). Levels of 8-isoprostane detected in chronic wound £uid
from both nonhealing and healing venous ulcers were signi¢-
cantly greater than those in acute wound £uid. This suggests that
there is a greater oxidative activity in chronic venous ulcers. This
is supported by other studies in which esteri¢ed F2-isoprostane
levels increase dramatically in tissues such as liver in animal mod-
els of free radical injury, and in which free F2-isoprostane is
found in every biologic £uid tested (plasma, urine, bile, gastric
juice, synovial £uid, and cerebrospinal £uid) (Morrow et al, 1992;
Morrow and Jackson Roberts, 1994). F2-isoprostanes are formed
in situ and are subsequently released preformed into the circula-
tion, presumably by a phospholipase(s) (Morrow et al, 1992) such
as PLA2 (Awad and Morrow, 1995). Therefore the higher levels of
free-form 8-isoprostane measured in chronic wound £uid may
indicate greater phospholipase activity in the chronic wound.
There was no signi¢cant di¡erence in 8-isoprostane levels in the
chronic wound £uid in the nonhealing phase compared to the
healing phase. This suggests that there is a continuing oxidative
activity in the chronic wounds. If the oxidative activity takes a
longer time to reduce, the 2 wk period of investigation may not
have been long enough to detect such alterations. If any altera-
tions over such a time period are only very small the sample size
may have been too small to detect such changes. Even though no
signi¢cant alteration in the levels of free 8-isoprostane was ob-
served between the nonhealing and healing chronic wound
£uids, the levels of esteri¢ed 8-isoprostane and phospholipid
may have changed during the 2 wk period and this requires
further investigation.
Not only are isoprostanes a reliable marker of oxidant injury,
these compounds are capable of exerting potent biologic activity.
Nanomolar amounts of free-form 8-isoprostane have been
shown to induce platelet activation, adhesiveness, and the expres-
sion of ¢brinogen receptors (Minuz et al, 1998). A recent study
demonstrated a physiologic e¡ect of 8-isoprostane in humans in
which 8-isoprostane could activate neutrophils to produce super-
oxide in a concentration-dependent manner.1 The fact that high
levels of this prostanoid are detected in the chronic wound £uid
raises questions of its biologic rami¢cation in the chronic wound.
High levels of 8-isoprostane in the wound £uid may exacerbate
tissue damage and delay healing in chronic wounds.
This study has shown that the levels of isoprostanes obtained
by the two methods di¡er considerably. The GC-ECNI-MS
method consistently measured lower levels than those of EIA
for both the chronic and acute wound £uid. The GC-ECNI-MS
method involved extensive sample puri¢cation coupled with
HPLC and ¢nally derivitization, which would result in the re-
moval of varying amounts of interfering substances. The EIA
method measures isoprostanes that bind to an antibody raised
against 8-iso-PGF2a and there is greater possibility that sub-
stances that are not removed in the less complicated sample pur-
i¢cation procedure might interfere in the assay. Di¡erences in
levels between the GC-ECNI-MS and EIA methods have been
observed in a study, in which urinary F2-isoprostanes were mea-
sured as markers of in vivo lipid peroxidation (Proudfoot et al,
1999).
A further contribution to free-radical-mediated tissue damage
may be an ine⁄cient antioxidant defense system. The status of
di¡erent enzymatic and nonenzymatic free radical scavengers
during wound healing is not completely understood. The total
antioxidant status in acute and chronic wound £uid was investi-
gated using one of the most commonly used total antioxidant ca-
pacity assays, the Randox Trolox equivalent antioxidant capacity
assay. Higher total antioxidant status was observed for chronic
wound £uid compared to acute wound £uid, suggesting an upre-
gulation of antioxidant activity to counterbalance the oxidative
activity in the chronic wound. A recent study showed there was
higher antioxidant activity in chronic leg ulcer exudates than was
observed in plasma ( James et al, 2001). There are reports that ser-
um from patients with rheumatoid arthritis has a higher anti-
oxidant activity towards iron-stimulated damage than serum
samples from normal subjects (Gutteridge, 1986). It has been pro-
posed that high total antioxidant status is a re£ection of uric acid
levels and results should be interpreted with caution (MacKinnon
et al, 1999). The uric acid levels in the acute and chronic wound
£uids were similar and this suggests that other antioxidants are
di¡erentially altered in the chronic wound £uid.
Lower total antioxidant status levels in acute wound £uid com-
pared to nonhealing and healing chronic leg ulcer wound £uid
can be explained in terms of a decrease in antioxidants following
wounding. Other studies have found a decrease in most enzy-
matic and nonenzymatic antioxidants in wounds less than 14 d
old (Shukla et al, 1997). A lower antioxidant level in acute wound
£uid could also imply that there was less oxidative activity in
acute wounds compared to chronic nonhealing wounds. This in
turn could lead to reduced induction of antioxidants.
This study provides further evidence of oxidative stress in
chronic wounds based on the elevation of 8-isoprostane levels
and the higher total antioxidant status in chronic wound £uid.
These data are consistent with other wound £uid studies, which
have found the allantoin:urate ratio (indicator of oxidative stress)
to be higher in chronic leg ulcer wound exudate compared to
acute surgical wound exudates and plasma.2 The relationship
between oxidative stress and antioxidant status would appear to
1Walsh SW,Vaughan JE: 8-isoprostane stimulates superoxide production
by human neutrophils. J Soc Gynecol Invest 5:129A, 1998 (abstr.)
2JamesTJ, Hughes MA, Hofman D, Cherry GW,Taylor RP: Evidence of
oxidative stress in chronic wounds.Wound Repair Regen 8:A420, 2000 (abstr.)
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mimic many other physiologic processes where an upregulation
of an active process is frequently associated with an upregulation
of its inhibitor. It can be speculated that the elevated antioxidants
in the chronic wound £uid were not su⁄cient to counterbalance
the oxidative nature of the chronic wound as supported by the
persistently higher level of 8-isoprostane.
This study has demonstrated changes in wound £uid from
chronic venous ulcers that support the concept that venous ulcers
have an environment of oxidative stress and oxidative-induced
cellular damage that may result from the presence of higher levels
of iron. Although this evidence does not conclusively prove this
association, it strongly suggests this concept and indicates the
need to undertake studies in which oxidative stress or damage is
minimized to determine whether this will lead to improvement
in the healing of venous ulcers.
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